Multiple Myeloma Among Topics in APSHO Educational Series for Healthcare Workers
The Advanced Practitioners Society for Hematology and Oncology…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreThe Advanced Practitioners Society for Hematology and Oncology…
Amgen reported findings from a post-hoc analysis of the pivotal Phase…
Researchers from Janssen Research & Development presented promising interim…
Celgene Corporation recently presented a study comparing overall survival, treatment…
The Multiple Myeloma Research Foundation (MMRF) has announced…
Researchers at the University of Louisville and collaborators from Japan…